We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 130

Failure to notify participant that coverage is out of network may be a fiduciary breach
  • Hodgson Russ LLP
  • USA
  • January 31 2014

The U.S. Court of Appeals for the Seventh Circuit, in an en banc decision, held that the husband of a deceased plan participant may continue with his


Medical device importers still required to submit device malfunction reports
  • Hodgson Russ LLP
  • USA
  • March 11 2011

In a notice dated Tuesday, March 8, 2011 (PDF), the FDA purports to clarify the requirements for reporting device malfunctions by device importers


Par pharmaceutical agrees to pay $45M to resolve liability
  • Hodgson Russ LLP
  • USA
  • March 6 2013

According to the Justice Department, Par Pharmaceutical Companies Inc. recently pleaded guilty and agreed to pay $45 million to resolve its liability


Mobile apps: the FDA is on its path of enforcement actions
  • Hodgson Russ LLP
  • USA
  • July 24 2013

Mobile health care is one of the most booming industries worldwide, with a strong potential for growth and an excellent financial prognosis. No


Departments issue wellness program final regulations
  • Hodgson Russ LLP
  • USA
  • July 31 2013

The Departments of Health and Human Services, Labor, and Treasury issued final wellness program regulations. These final rules are applicable to


2014 limitations for health savings accounts announced
  • Hodgson Russ LLP
  • USA
  • July 31 2013

The IRS has released the inflation-adjusted limitation amounts for health savings accounts (HSA) for 2014. The limitation on deductions for


$17 million false claims judgment entered against D.C. doctor
  • Hodgson Russ LLP
  • USA
  • August 1 2013

According to a recent Justice Department press release, a D.C. federal court entered a $17 million False Claims Act judgment against Dr. Ishtiaq


Research grant fraud
  • Hodgson Russ LLP
  • USA
  • June 3 2014

False Claims Act practitioners at recent gatherings seem to agree that research grant fraud will be a growing area of whistleblower activity. As the


Sunshine Act data collection checklist
  • Hodgson Russ LLP
  • USA
  • August 13 2013

As we discussed in an earlier post, the data collection obligations under the Physician Payment Sunshine Act commenced on August 1, 2013, and all


The application of the medical device excise tax to foreign manufacturers selling to end-users in the United States
  • Hodgson Russ LLP
  • USA
  • May 6 2013

As of January 1, 2013, the first sale of a taxable medical device in the United States by a manufacturer, producer, or importer has been subject to a